TY - JOUR
T1 - Artificial microRNA suppresses C9ORF72 variants and decreases toxic dipeptide repeat proteins in vivo
AU - Cabrera, Gabriela Toro
AU - Meijboom, Katharina E.
AU - Abdallah, Abbas
AU - Tran, Helene
AU - Foster, Zachariah
AU - Weiss, Alexandra
AU - Wightman, Nicholas
AU - Stock, Rachel
AU - Gendron, Tania
AU - Gruntman, Alisha
AU - Giampetruzzi, Anthony
AU - Petrucelli, Leonard
AU - Brown, Robert H.
AU - Mueller, Christian
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Nature Limited 2023.
PY - 2024/3
Y1 - 2024/3
N2 - Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that affects motor neurons, causing progressive muscle weakness and respiratory failure. The presence of an expanded hexanucleotide repeat in chromosome 9 open reading frame 72 (C9ORF72) is the most frequent mutation causing familial ALS and frontotemporal dementia (FTD). To determine if suppressing expression of C9ORF72 gene products can reduce toxicity, we designed a set of artificial microRNAs (amiRNA) targeting the human C9ORF72 gene. Here we report that an AAV9-mediated amiRNA significantly suppresses expression of the C9ORF72 mRNA, protein, and toxic dipeptide repeat proteins generated by the expanded repeat in the brain and spinal cord of C9ORF72 transgenic mice.
AB - Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that affects motor neurons, causing progressive muscle weakness and respiratory failure. The presence of an expanded hexanucleotide repeat in chromosome 9 open reading frame 72 (C9ORF72) is the most frequent mutation causing familial ALS and frontotemporal dementia (FTD). To determine if suppressing expression of C9ORF72 gene products can reduce toxicity, we designed a set of artificial microRNAs (amiRNA) targeting the human C9ORF72 gene. Here we report that an AAV9-mediated amiRNA significantly suppresses expression of the C9ORF72 mRNA, protein, and toxic dipeptide repeat proteins generated by the expanded repeat in the brain and spinal cord of C9ORF72 transgenic mice.
UR - http://www.scopus.com/inward/record.url?scp=85172234220&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85172234220&partnerID=8YFLogxK
U2 - 10.1038/s41434-023-00418-w
DO - 10.1038/s41434-023-00418-w
M3 - Article
C2 - 37752346
AN - SCOPUS:85172234220
SN - 0969-7128
VL - 31
SP - 105
EP - 118
JO - Gene Therapy
JF - Gene Therapy
IS - 3-4
ER -